Post-approval studies (Phase 4)UnknownNCT03260556What this trial is testingPirfenidone for Progressive Fibrotic SarcoidosisWho this might be right forSarcoidosis, Pulmonary University of Cincinnati 60
Testing effectiveness (Phase 2)UnknownNCT05118256What this trial is testingPirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated SilicosisWho this might be right forSilicosisProgressive Massive FibrosisComplicated Silicosis Instituto de investigación e innovación biomédica de Cádiz 18
Early research (Phase 1)Looking for participantsNCT06821464What this trial is testingA Trial of HRS-9813 in Healthy SubjectsWho this might be right forIdiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis Guangdong Hengrui Pharmaceutical Co., Ltd 60
Testing effectiveness (Phase 2)Looking for participantsNCT06714123What this trial is testingSenicapoc in Patients With Worsening Fibrotic Interstitial Lung DiseaseWho this might be right forPulmonary Fibrosis, Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis Vejle Hospital 140
Not applicableStudy completedNCT05875532What this trial is testingStudy of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and TreatmentWho this might be right forLung Diseases, Interstitial Boehringer Ingelheim 34,960
Large-scale testing (Phase 3)Not Yet RecruitingNCT07503587What this trial is testingEvaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary FibrosisWho this might be right forProgressive Pulmonary Fibrosis Haisco Pharmaceutical Group Co., Ltd. 378
Not applicableUnknownNCT05450276What this trial is testingPatient-Reported Outcome Study of Project ECHO for ILDWho this might be right forInterstitial Lung Disease Pulmonary Care and Research Collaborative Limited 56
Testing effectiveness (Phase 2)Study completedNCT02594839What this trial is testingSafety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung DiseaseWho this might be right forIdiopathic Interstitial PneumoniaInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 20
Testing effectiveness (Phase 2)Study completedNCT04308681What this trial is testingA Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung FibrosisWho this might be right forPulmonary Fibrosis Bristol-Myers Squibb 403
Testing effectiveness (Phase 2)Ended earlyNCT04837131What this trial is testingEvaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease PatientsWho this might be right forSystemic SclerosisSclerodermaDiffuse Systemic Sclerosis+16 more Michael M. Pham 4
Post-approval studies (Phase 4)Study completedNCT02096107What this trial is testingNovartis Everolimus TransitionWho this might be right forGraft DysfunctionInterstitial Fibrosis Medical University of South Carolina 60
Not applicableLooking for participantsNCT07332117What this trial is testingA Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic MedicationsWho this might be right forIdiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis Royal Brompton & Harefield NHS Foundation Trust 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05828953What this trial is testingAnlotinib Capsules in the Treatment for IPF/PF-ILDsWho this might be right forInterstitial Lung Diseases First Affiliated Hospital of Wenzhou Medical University 30
Large-scale testing (Phase 3)Enrolling By InvitationNCT04905693What this trial is testingExtension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseaseWho this might be right forIdiopathic Pulmonary FibrosisInterstitial Lung DiseaseProgressive Pulmonary Fibrosis United Therapeutics 1,850
Testing effectiveness (Phase 2)Looking for participantsNCT06329401What this trial is testingA Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisWho this might be right forPulmonary FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis Secondary to Systemic Sclerosis+7 more Avalyn Pharma Inc. 375
Not applicableLooking for participantsNCT06537934What this trial is testingAdvanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung DiseasesWho this might be right forInterstitial Lung Diseases IRCCS San Raffaele 123
Testing effectiveness (Phase 2)Looking for participantsNCT06951217What this trial is testingAn Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)Who this might be right forProgressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF) Avalyn Pharma Inc. 340
Not applicableLooking for participantsNCT07269262What this trial is testingSUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their CaregiversWho this might be right forProgressive Pulmonary FibrosisInterstitial Lung Disease Medical University of South Carolina 170
Large-scale testing (Phase 3)Looking for participantsNCT05943535What this trial is testingStudy of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)Who this might be right forProgressive Pulmonary FibrosisInterstitial Lung Disease United Therapeutics 698
Not applicableUnknownNCT05445817What this trial is testingPulmonary Care and Research Collaborative Patient RegistryWho this might be right forInterstitial Lung Disease Pulmonary Care and Research Collaborative Limited 150